# The Ideal Sequence of Hybrid Coronary Revascularization with Endoscopic Coronary Revascularization

> **NCT05184075** · NA · TERMINATED · sponsor: **Jessa Hospital** · enrollment: 4 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **PROCEDURE:** Standard hybrid coronary revascularization
- **PROCEDURE:** Reverse hybrid coronary revascularization

## Key facts

- **NCT ID:** NCT05184075
- **Lead sponsor:** Jessa Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-01-09
- **Primary completion:** 2024-11-09
- **Final completion:** 2024-11-09
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** After the passing of the cardiac surgeon, the clinical trial could not be continued.
- **Last updated:** 2024-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05184075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05184075, "The Ideal Sequence of Hybrid Coronary Revascularization with Endoscopic Coronary Revascularization". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05184075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*